Sequenom

Bringing the power of science to healthcare. Sequenom, Inc. (NASDAQ: SQNM) is committed to enabling healthier lives through the development of innovative products and services. We serve patients and physicians by providing early patient management information. What makes this vision a reality? Our deep commitment to "Quality of Science." For us, only the highest quality is acceptable. We accept nothing less in the science that supports every product and service we offer. From development to commercialization of innovative tests, "Quality of Science" is the common element in everything we do.
Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
1994
Size (employees)
434 (est)
Sequenom was founded in 1994 and is headquartered in San Diego, US

Sequenom Office Locations

Sequenom has offices in San Diego, Salt Lake City, New York, Philadelphia and in 17 other locations
San Diego, US (HQ)
3595 John Hopkins Ct

Sequenom Metrics

Sequenom Financial Metrics

Revenue (2015)

$128.3 m

Revenue growth (2014-15), %

(15%)

Gross profit

$61.3 m

Gross profit margin (2015), %

48%

Net income (2015)

($16.3 m)

Market capitalization (01-Sep-2016)

$286.2 m

Closing share price (01-Sep-2016)

$2.4

Cash (31-Dec-2015)

$50.3 m
Sequenom's current market capitalization is $286.2 m.
Sequenom's revenue was reported to be $128.3 m in FY, 2015 which is a 15.4% decrease from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

$162.4 m$151.6 m$128.3 m

Revenue growth, %

(7%)(15%)

Cost of goods sold

$102.7 m$83.5 m$67 m

Gross profit

$59.7 m$68.1 m$61.3 m

Gross profit Margin, %

37%45%48%

R&D expense

$25 m

General and administrative expense

$46.9 m

Operating expense total

$158.1 m$104.6 m$157.9 m

EBIT

($98.4 m)($13.7 m)($7.9 m)

EBIT margin, %

(61%)(9%)(6%)

Interest expense

$8.4 m$8.2 m$8.1 m

Interest income

$55 k$71 k

Pre tax profit

($107.1 m)($22 m)($16.1 m)

Income tax expense

($301 k)($7.7 m)($244 k)

Net Income

($107.4 m)$1 m($16.3 m)
FY, 2013FY, 2014FY, 2015

Cash

$61.6 m$63.3 m$50.3 m

Accounts Receivable

$10.2 m$9.1 m$6.4 m

Inventories

$17 m$6.5 m$2.4 m

Current Assets

$101.5 m$121.7 m$89 m

Goodwill

$10 m$10 m$10 m

Total Assets

$144.7 m$161.1 m$118.8 m

Accounts Payable

$10 m$6.1 m$5.2 m

Current Liabilities

$49.6 m$56 m$21.5 m

Additional Paid-in Capital

$967 m$981.9 m$991 m

Retained Earnings

($1 b)($1 b)($1 b)

Total Equity

($31.2 m)($38.4 m)

Financial Leverage

-5.2 x-3.1 x
FY, 2013FY, 2014FY, 2015

Net Income

($107.4 m)$1 m($16.3 m)

Depreciation and Amortization

$15.1 m$12.2 m

Accounts Receivable

($2.3 m)($6.6 m)

Inventories

($6.2 m)$5.1 m

Accounts Payable

($90 k)($5.7 m)

Cash From Operating Activities

($85.6 m)($28.1 m)($13 m)

Cash From Investing Activities

$29.4 m$32.9 m

Interest Paid

$7.4 m$7.1 m

Sequenom Online Presence

Sequenom News

Sequenom Company Life

You may also be interested in